Releases & Announcements

In the Spotlight

Dr. Steven Kahn, study chair for the RISE Consortium, talks with RISE participant Faamafi Faamafi Jr. about his experience in the adult medication trial. Photo: Christopher Pacheco, VA Puget Sound Health Care System

Improvements in Insulin Release Wane after Treatment Stops in Adults with Early Type 2 Diabetes

NCATS, NIDDK ∙ 06/10/2019 ∙ CTSA Program

A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment.

June 2019

Improvements in Insulin Release Wane after Treatment Stops in Adults with Early Type 2 Diabetes
NCATS, NIDDK ∙ 06/10/2019 ∙ CTSA Program

May 2019

Human Antibody Reveals Hidden Vulnerability in Influenza Virus
NCATS, NIAID ∙ 05/16/2019 ∙ CTSA Program